CTRI/2014/01/004369
Recruiting
Phase 4
â??Comparison of efficacy and safety ofintravenous ferric carboxymaltose vs iron sucrose in the treatment of antepartum iron deficiency anaemia â?? A randomized controlled trialâ??
KLE Hospital0 sites230 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- KLE Hospital
- Enrollment
- 230
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Antepartum women whose haemoglobin is in the range of 7 to 10 gm/dl
Exclusion Criteria
- •women not willing to participate
- •women in labor
- •serious medical complications
- •women who have a history or known allergic to parentral iron infusion
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
comparing the efficacy and safety ofintralesional acyclovir in two concentration in common wartsHealth Condition 1: L088- Other specified local infections of the skin and subcutaneous tissueCTRI/2024/02/063057Dr RPGMC Kangra at Tanda
Completed
Not Applicable
Comparative study of the efficacy and safety of intranasal ketamine and midazolam for the acute treatment of migraine with prolonged auraMigraineNervous System DiseasesISRCTN18446134Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)30
Not yet recruiting
Not Applicable
Safety and efficacy of Intrathecal Morphine as an Analgesic in Post-operative Total Knee ReplacementHealth Condition 1: M170- Bilateral primary osteoarthritis of kneeHealth Condition 2: O- Medical and SurgicalCTRI/2021/05/033462Dr Dipak Desai
Recruiting
Not Applicable
The study on the efficacy and safety of combination of low dose propiverine hydrocholoride and alpha-antagonist in men with BPH with overactive bladderDiseases of The genitoruinary systemKCT0000077Inha University Hospital236
Completed
Not Applicable
comparison of various respiratory medicines in patients with chronic airway disease of prolong duratioHealth Condition 1: null- chronic obstructive pulmonary diseaseHealth Condition 2: J449- Chronic obstructive pulmonary disease, unspecifiedHealth Condition 3: J449- Chronic obstructive pulmonary disease, unspecifiedCTRI/2018/06/014573Department of pharmacology160